Show simple item record

dc.contributor.authorAnwer, Faiz
dc.contributor.authorYun, Seongseok
dc.contributor.authorNair, Anju
dc.contributor.authorAhmad, Yusuf
dc.contributor.authorKrishnadashan, Ravitharan
dc.contributor.authorDeeg, H. Joachim
dc.date.accessioned2016-07-19T00:59:58Z
dc.date.available2016-07-19T00:59:58Z
dc.date.issued2015
dc.identifier.citationSevere Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag 2015, 2015:1 Case Reports in Hematologyen
dc.identifier.issn2090-6560
dc.identifier.issn2090-6579
dc.identifier.doi10.1155/2015/583451
dc.identifier.urihttp://hdl.handle.net/10150/617180
dc.descriptionUA Open Access Publishing Funden
dc.description.abstractSevere refractory ITP is clinically challenging and a variety of single or combination chemotherapies have been tried with limited outcome. We report a case of ITP that was unresponsive to multiple agents including high-dose steroid, IVIG, Rho(D) immune globulin, rituximab, cyclosporine, azathioprine, vincristine, mycophenolate mofetil, romiplostim, and eltrombopag; however, it achieved complete remission with combination treatment of cyclophosphamide and eltrombopag.
dc.language.isoenen
dc.publisherHindawien
dc.relation.urlhttp://www.hindawi.com/journals/crihem/2015/583451/en
dc.rightsCopyright © 2015 Faiz Anwer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproductio n in any medium, provided the original work is properly cited.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleSevere Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopagen
dc.typeArticleen
dc.contributor.departmentDepartment of Medicine, University of Arizonaen
dc.identifier.journalCase Reports in Hematologyen
dc.description.noteOpen access.en
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
refterms.dateFOA2018-06-16T15:13:50Z
html.description.abstractSevere refractory ITP is clinically challenging and a variety of single or combination chemotherapies have been tried with limited outcome. We report a case of ITP that was unresponsive to multiple agents including high-dose steroid, IVIG, Rho(D) immune globulin, rituximab, cyclosporine, azathioprine, vincristine, mycophenolate mofetil, romiplostim, and eltrombopag; however, it achieved complete remission with combination treatment of cyclophosphamide and eltrombopag.


Files in this item

Thumbnail
Name:
583451.pdf
Size:
1.231Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © 2015 Faiz Anwer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproductio n in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as Copyright © 2015 Faiz Anwer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproductio n in any medium, provided the original work is properly cited.